Calling All Spine and Neuro Warriors — Ever stared down a case of spinal or pelvic diffuse large B-cell lymphoma (SP-DLBCL) and thought, “I could surely use a validated crystal ball right about now”?
Well, the researchers of this latest study can’t promise mystical insight, but they can introduce you to something close: a shiny new competing risk-based nomogram and an online calculator designed to predict spinal or pelvic diffuse large B-cell lymphoma survival (CSS).
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
